Skip to main content

Uterine Fibroids clinical trials at UCLA

3 in progress, 1 open to eligible people

Showing trials for
  • Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

    open to eligible females ages 18-50

    The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.

    Los Angeles, California and other locations

  • Addition of Steroids on Duration of Analgesia

    Sorry, in progress, not accepting new patients

    The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.

    Westwood, Los Angeles, California and other locations

  • Prescription of Letrozole for Uterine Myoma

    Sorry, not currently recruiting here

    The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.

    Los Angeles, California and other locations

Our lead scientists for Uterine Fibroids research studies include .

Last updated: